115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Avelumab plus axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial
    Meeting Abstract

    Motzer, R. J.; Penkov, K.; Uemura, H.; Campbell, M. T.; Kollmannsberger, C. K.; Lee, J. L.; Venugopal, B.; Van Den Eertwegh, A.; Negrier, S.; Gurney, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Hope drives quality of life in patients with brain metastases, but the hope center remains elusive: An analysis of NRG-CC003
    Meeting Abstract

    Corn, B. W.; Paulus, R.; Gondi, V.; Mehta, M. P.; Fogh, S. E.; Wefel, J. S.; Videtic, G. M. M.; Sun, A.; Yoon, H.; Heinzerling, J. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study
    Meeting Abstract

    Rojas, C.; Eskens, F.; Ghiringhelli, F.; Özgüroglu, M.; Caglevic, C.; Gumus, M.; Tosi, D.; Grenier, J.; Gonzalez, A. F.; Arenas, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlative biomarker analyses for optimal therapeutic dose determination of ABBV-383, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ahsan, A.; Mantis, C.; Luo, X.; Zhang, C. C.; Valdes, C. R.; Voorhees, P. M.; D'Souza, A.; Chung, A.; Tuchman, S.; Safah, H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Peak study: A phase 3, randomized, open-label multi-center clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST)
    Meeting Abstract

    Tap, W. D.; Somaiah, N.; Kang, Y. K.; Ryan, A.; Razak, A.; Garrido, M.; Desar, I. M. E.; Italiano, A.; Reichardt, P.; Wilky, B. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Evaluation of cytokine release syndrome (CRS) in patients with relapsed or refractory multiple myeloma (RRMM) receiving step-up priming doses and longer dosing intervals of elranatamab: MagnetisMM-9
    Meeting Abstract

    Sborov, D. W.; Pawlyn, C.; Ishida, T.; Huang, J. S. Y.; Benjamin, R.; Iida, S.; Popat, R.; Kuroda, J.; Pianko, M. J.; Ramakrishnan, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC)
    Meeting Abstract

    Colevas, A. D.; Chung, C. H.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Sukari, A.; Worden, F. P.; Johnson, F. M.; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • NRG Oncology/RTOG 0848: Results after adjuvant chemotherapy +/- chemoradiation for patients with resected periampullary pancreatic adenocarcinoma (PA)
    Meeting Abstract

    Abrams, R. A.; Winter, K. A.; Goodman, K. A.; Regine, W.; Safran, H.; Berger, A. C.; Guha, C.; Kachnic, L. A.; Gillin, M.; Seaward, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS)
    Meeting Abstract

    Lacuna, K. P.; Ingham, M.; Chen, L.; Das, B.; Lee, S. M.; Ge, L.; Druta, M.; Conley, A. P.; Keohan, M. L.; Agulnik, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 3 dose selection for selinexor in TP53wt endometrial cancer based on exposure-response analysis
    Meeting Abstract

    Makker, V.; Richardson, D. L.; Chon, H. S.; Miller, D. S.; Mau-Sorensen, M.; Cibula, D.; Zagouri, F.; Fidalgo, A. P.; Slomovitz, B. M.; Coleman, R. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save